Literature DB >> 1541677

Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release.

C Bernard1, B Szekely, I Philip, E Wollman, D Payen, A Tedgui.   

Abstract

Inflammatory mediators released by macrophages (M phi) are believed to be involved in septic vasoplegia. To investigate the effect of M phi on vascular reactivity, excised rabbit carotids were exposed intraluminally either to peritoneal rabbit M phi, activated by 18 h of incubation with 1 microgram/ml lipopolysaccharide, or to the supernatants (SPN) derived from them. The contractile responses to phenylephrine (PE, 10(-6) M) were determined by measuring changes in diameter using an ultrasonic microdimensiometer 1, 2, and 3 h after the first control contraction. In control arteries (n = 12), PE-induced contractions were, respectively, 102.9 +/- 3.3%, 95.2 +/- 4.1%, and 89.7 +/- 3.8% of the first contraction, after 1, 2, and 3 h. Activated M phi significantly reduced PE-stimulated contractions after as little as 1 h of carotid exposure (percentage of controls at 1, 2, or 3 h: 74.1 +/- 5.6, 57.2 +/- 5.2, and 34.2 +/- 5.6, n = 10, P less than 0.001). The activated macrophage-derived SPN took longer to diminish carotid contractility than the M phi themselves, and became significant only after 2 h. The greater effect of M phi might be due to cooperation between M phi and vascular cells, as suggested by the amplified interleukin-1 release observed after M phi infusion. The presence of the endothelium partially protected carotid contractility from depression by activated M phi. Extraluminal addition of NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis prevented this depression in arteries with or without endothelium. No products of the oxidative pathway of L-arginine were detected in rabbit activated M phi. These results suggest that activation of this pathway in smooth muscle cells seems to be involved in vascular hypocontractility.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541677      PMCID: PMC442930          DOI: 10.1172/JCI115664

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

Review 1.  Native interleukin 1 inhibitors.

Authors:  J W Larrick
Journal:  Immunol Today       Date:  1989-02

2.  Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.

Authors:  R G Kilbourn; P Belloni
Journal:  J Natl Cancer Inst       Date:  1990-05-02       Impact factor: 13.506

Review 3.  Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance.

Authors:  J L Dinerman; J L Mehta
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

4.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.

Authors:  D Beasley; J H Schwartz; B M Brenner
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle.

Authors:  E H Ohlstein; A J Nichols
Journal:  Circ Res       Date:  1989-10       Impact factor: 17.367

8.  NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

Authors:  R G Kilbourn; S S Gross; A Jubran; J Adams; O W Griffith; R Levi; R F Lodato
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA.

Authors:  N Takasuka; T Tokunaga; K S Akagawa
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

10.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.

Authors:  C Natanson; P W Eichenholz; R L Danner; P Q Eichacker; W D Hoffman; G C Kuo; S M Banks; T J MacVittie; J E Parrillo
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  4 in total

1.  Impaired lymphatic contraction associated with immunosuppression.

Authors:  Shan Liao; Gang Cheng; David A Conner; Yuhui Huang; Raju S Kucherlapati; Lance L Munn; Nancy H Ruddle; Rakesh K Jain; Dai Fukumura; Timothy P Padera
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Systemic pressure-flow reactivity to norepinephrine in rabbits: impact of endotoxin and fluid loading.

Authors:  A Ricard-Hibon; M R Losser; R Kong; S Beloucif; B Teisseire; D Payen
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

3.  The adventitia may be a barrier specific to nitric oxide in rabbit pulmonary artery.

Authors:  R H Steinhorn; F C Morin; J A Russell
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

4.  Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status.

Authors:  Imad Abboud; Nicolas Lerolle; Saik Urien; Jean-Marc Tadié; Françoise Leviel; Jean-Yves Fagon; Christophe Faisy
Journal:  Crit Care       Date:  2009-07-21       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.